The role of CMV in glioblastoma and implications for immunotherapeutic strategies

Por Rahman, Maryam, Dastmalchi, Farhad, Karachi, Aida, Mitchell, Duane
Publicado no Oncoimmunology (2018)

Temozolomide for immunomodulation in the treatment of glioblastoma

Por Karachi, Aida, Dastmalchi, Farhad, Mitchell, Duane A, Rahman, Maryam
Publicado no Neuro Oncol (2018)

IMMU-57. STRATEGY TO ENHANCE DC MIGRATION FOR INCREASED EFFICACY OF DENDRITIC CELL VACCINE IMMUNOTHERAPY

Por Dastmalchi, Farhad, Karachi, Aida, Azari, Hassan, Mitchell, Duane, Rahman, Maryam
Publicado no Neuro Oncol (2017)

TMIC-26. IMMUNOMODULATION WITH TEMOZOLOMIDE TO IMPROVE EFFICACY OF IMMUNE CHECKPOINT INHIBITION FOR THE TREATMENT OF GLIOBLASTOMA

Por Karachi, Aida, Dastmalchi, Farhad, Yang, Changlin, Huang, Jianping, Mitchell, Duane, Rahman, Maryam
Publicado no Neuro Oncol (2017)

METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS

Por Dastmalchi, Farhad, Karachi, Aida, Khattri, Ram, Merritt, Matthew E, Mitchell, Duane, Rahman, Maryam
Publicado no Neuro Oncol (2017)

IMMU-31. IN VIVO CELLULAR TRACKING WITH (13)C LABELING OF ADOPTIVELY TRANSFERRED T CELLS FOR THE TREATMENT OF BRAIN TUMORS

Por Dastmalchi, Farhad, Karachi, Aida, Allison, Jonathan R, Basso, Kari B, Mitchell, Duane, Rahman, Maryam
Publicado no Neuro Oncol (2017)

IMMU-45. DOSE MODULATION OF TEMOZOLOMIDE HAVE DISTINCT EFFECTS ON HOST RESPONSE TO PD-1 BLOCKADE

Por Karachi, Aida, Dastmalchi, Farhad, Yang, Changlin, Huang, Jianping, Sayour, Elias, Mitchell, Duane, Rahman, Maryam
Publicado no Neuro Oncol (2018)

IMMU-66. A NOVEL METABOLITE TO INCREASE EFFICACY OF CELLULAR IMMUNOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA

Por Dastmalchi, Farhad, Karachi, Aida, Vlasak, Alexander, Azari, Hassan, Baban, Usma, Mitchell, Duane, Rahman, Maryam
Publicado no Neuro Oncol (2018)

DRES-13. VEGF BLOCKADE ENHANCES T REGULATORY CELL FUNCTION BY DYSREGULATING GLUTAMATE TRANSPORT IN GBM

Por Long, Yu, Karachi, Aida, Grippin, Adam, Tao, Haipeng, Zhang, Wang, Sayour, Elias, Deleyrolle, Loic, Mitchell, Duane, Lin, Zhiguo, Huang, Jianping
Publicado no Neuro Oncol (2018)

Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition

Por Karachi, Aida, Yang, Changlin, Dastmalchi, Farhad, Sayour, Elias J, Huang, Jianping, Azari, Hassan, Long, Yu, Flores, Catherine, Mitchell, Duane A, Rahman, Maryam
Publicado no Neuro Oncol (2019)

STEM-09. CANCER STEM CELL IMMUNOEDITING

Por Sayour, Elias, Yang, Changlin, Grippin, Adam, Mendez-Gomez, Hector, Dajac, Mariana, Nazareth, Brian, Andrews, Michael, Loche, Tyler, Karachi, Aida, Stover, Brian, Moore, Ginger, Kresak, Jesse, Huang, Jianping, Mitchell, Duane, Deleyrolle, Loic
Publicado no Neuro Oncol (2018)

IMMU-56. CXCR1/2 MODIFIED CARs CO-OPT RADIATION-INDUCED IL-8 FOR ENHANCED CHEMOTAXIS OF THE CAR T CELLS AND MAXIMAL ANTI-TUMOR EFFICACY

Por Jin, Linchun, Tao, Haipeng, Zhang, Wang, Long, Yu, Dyson, Kyle, Karachi, Aida, Deleyrolle, Loic, Sayour, Elias, Rahman, Maryam, Mitchell, Duane, Rajon, Didier, Yang, Changlin, Kubilis, Paul, Bova, Frank, Lin, Zhiguo, Huang, Jianping
Publicado no Neuro Oncol (2018)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas

Por Mu, Luyan, Long, Yu, Yang, Changlin, Jin, Linchun, Tao, Haipeng, Ge, Haitao, Chang, Yifan E., Karachi, Aida, Kubilis, Paul S., De Leon, Gabriel, Qi, Jiping, Sayour, Elias J., Mitchell, Duane A., Lin, Zhiguo, Huang, Jianping
Publicado no Front Mol Neurosci (2018)